Viral diagnostics in the arena of blood donor screening

Vox Sanguinis, Supplement

Volumn 87, Issue 2, 2004, Pages

  Stramer, S L ^a  

^a AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BLOOD DONOR; CONFERENCE PAPER; COUNSELING; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; PARVOVIRUS; PRIORITY JOURNAL; SCREENING; VIRUS DIAGNOSIS; WEST NILE FLAVIVIRUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BLOOD; BLOOD BANKS; BLOOD DONORS; BLOOD TRANSFUSION; BLOTTING, WESTERN; COMMUNICABLE DISEASE CONTROL; HEPATITIS A; HEPATITIS B; HEPATITIS C; HIV SEROPOSITIVITY; HUMANS; IMMUNOENZYME TECHNIQUES; PARVOVIRUS; RNA, VIRAL; WEST NILE FEVER;

EID: 4444317906     PISSN: 17416892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Dodd RY, Notari EP, Stramer SL: Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002; 42:975-979
2. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Cagliot S, Wright DJ, Dodd RY, Busch MP: Detection of HIV-1 and HCV infections among antibody-negative V5 blood donors by nucleic acid amplification testing. N Engl J Med 2004; in press
3. Dodd RY, Stramer SL: Indeterminate results in blood donor testing: what you don't know can hurt you. Trans Med Rev 2000; 14:151-160
4. Kleinman S, Busch MP, Hall L, Thomson R, Glynn S, Gallahan D, Ownby HE, Williams AE: False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. JAMA 1998; 280:1080-1085
5. Cyrus S, Robertson G, Caglioti S, Allmond SE, Brodsky JP, Stramer SL: Evaluation of an alternate HIV confirmatory testing algorithm. Transfusion 2002; 43:S131-S040K
6. Tobler LH, Stramer SL, Kleinman SH, Brodsky JP, Todd DS, Busch MP: Misclassification of HCV viremic blood donors as indeterminate by RIBA 3·0 because of human superoxide dismutase activity. Transfusion 2001; 41:1625-1626
7. Centers for Disease Control and Prevention: Guidelines for Laboratory Testing and Result Reporting of Antibody to Hepatitis C Virus. MMWR 2003 52 (RR-3): 1-16
8. Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW, Peddeda L, Smith R, Schreiber GB, Epstein JS, Nemo GJ, Busch MP: Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003; 43:788-798
9. Kleinman SH, Kuhns M, Todd DS, Glynn SA, McNamara A, DiMarco A, Busch MP: Frequency of HBVDNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003; 43:696-704
10. Pietrelli L, Gorlin J, Holland P, Strong M, Cousins C, Tegtmeier G: A prospective study to evaluate the screening of plasma pools form volunteer blood donations for the presence of HBV DNA. Transfusion 2003; 43:S86-S040C
11. Pealer LN, Marfin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL, Stobierski MG, Signs K, Newman B, Kapoor H, Goodman JL, Chamberland ME: Transmission of West Nile Virus through blood transfusion in the United States 2002. N Engl J Med 2003; 349:1236-1245
12. Dodd RY: Emerging infections, transfusion safety, and epidemiology. N Engl J Med 2003; 349:1205-1206
13. Centers for Disease Control and Prevention: Update. Detection West Nile Virus Blood Donations-United States, 2003 MMWR 2003;52:916-919
14. Centers for Disease Control and Prevention: Erratum. Detection West Nile Virus Blood Donations-United States, 2003 MMWR 2003; 52:1160
15. Centers for Disease Control and Prevention: Update. West Nile virus screening of blood donations and transfusion-associated transmission-United States, 2003. MMWR 2004; 53:281-4
16. Young NS, Brown KE: Parovirus B19. N Engl J Med 2004; 350:586-597
17. Bower WA, Nainan OV, Han X, Margolis HS: Duration of viremia in hepatitis A infection. J Infect Dis 2000; 182:12-17